O. Tezcan

Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells.

R. Weiskirchen, T. Lammers, Steffen K. Meurer, 2020, Cellular signalling.

Targeting cellular and microenvironmental multidrug resistance

F. Kiessling, G. Storm, T. Lammers, 2016, Expert Opinion on Drug Delivery.

Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization

R. Carter, Sunil Krishnan, A. Liopo, 2022, Science advances.

Vimentin silencing effect on invasive and migration characteristics of doxorubicin resistant MCF-7 cells.

U. Gündüz, O. Tezcan, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Effect of cellular and microenvironmental multidrug resistance on tumor-targeted drug delivery in triple-negative breast cancer.

F. Kiessling, T. Etrych, R. Weiskirchen, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin.

K. Ulbrich, W. Hennink, T. Etrych, 2017, Nanoscale.